138 related articles for article (PubMed ID: 10568224)
21. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
22. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
Park JH; Park KH; Cho S; Choi YS; Seo SK; Lee BS; Park HS
Menopause; 2013 Jul; 20(7):747-53. PubMed ID: 23511701
[TBL] [Abstract][Full Text] [Related]
23. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
[TBL] [Abstract][Full Text] [Related]
24. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
25. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
26. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
Sahota O; Fowler I; Blackwell PJ; Lawson N; Cawte SA; San P; Masud T; Hosking DJ
Osteoporos Int; 2000; 11(11):959-66. PubMed ID: 11193249
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
Jeffery JR; Leslie WD; Karpinski ME; Nickerson PW; Rush DN
Transplantation; 2003 Nov; 76(10):1498-502. PubMed ID: 14657693
[TBL] [Abstract][Full Text] [Related]
28. Effect of low-dose calcitriol and calcium therapy on bone histomorphometry and urinary calcium excretion in osteopenic women.
Arthur RS; Piraino B; Candib D; Cooperstein L; Chen T; West C; Puschett J
Miner Electrolyte Metab; 1990; 16(6):385-90. PubMed ID: 2089252
[TBL] [Abstract][Full Text] [Related]
29. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
[TBL] [Abstract][Full Text] [Related]
30. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
Gallagher JC
J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
[TBL] [Abstract][Full Text] [Related]
32. [Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis].
Shostak NA; Muradiants AA; Kondrashov AA; Denisova SN
Vopr Pitan; 2014; 83(5):79-85. PubMed ID: 25816630
[TBL] [Abstract][Full Text] [Related]
33. Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Gutteridge DH
N Engl J Med; 2004 May; 350(22):2306-8; author reply 2306-8. PubMed ID: 15163785
[No Abstract] [Full Text] [Related]
34. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
Need AG; Horowitz M; Philcox JC; Nordin BE
Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
[TBL] [Abstract][Full Text] [Related]
35. Effect of supplemental calcium on serum and urinary calcium in osteoporotic patients.
Licata AA; Jones-Gall D
J Am Coll Nutr; 1992 Apr; 11(2):164-7. PubMed ID: 1578092
[TBL] [Abstract][Full Text] [Related]
36. [The effects of the carbocalcitonin + arginine-lysine-lactose combination in senile involutional osteoporosis].
Abate G; Taormina F; Brillante C; Fraccalaglio L
Minerva Med; 1994 May; 85(5):253-9. PubMed ID: 8028755
[TBL] [Abstract][Full Text] [Related]
37. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.
Lopez I; Mendoza FJ; Guerrero F; Almaden Y; Henley C; Aguilera-Tejero E; Rodriguez M
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1376-85. PubMed ID: 19321594
[TBL] [Abstract][Full Text] [Related]
38. Treatments for osteoporosis in postmenopausal women.
Brockie J
Community Nurse; 1999 Jul; 5(6):32-3. PubMed ID: 10524029
[No Abstract] [Full Text] [Related]
39. Alendronate treatment for osteoporosis.
Brager R
Adv Nurse Pract; 1997 Mar; 5(3):28-34. PubMed ID: 9459879
[No Abstract] [Full Text] [Related]
40. [Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis].
Bellati U; Liberati M
Minerva Med; 1994 Jun; 85(6):327-32. PubMed ID: 8084436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]